InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Franson Timothy R, 董事. Officer active across 2 companies, notably Cidara Therapeutics, Inc.. In total, 5 reports have been published. Split: 1 buy · 1 sell. Total volume traded: €25k. Activity tracked since 13 September 2021. The latest transaction was filed on 21 February 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Franson Timothy R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
52,000 股Common StockSEC:0000899243-23-019355:0
7,000 股@ US$1.88100.0% 占其流量Common StockSEC:0000904454-23-000176:0
20,000 股0Common StockSEC:0000904454-23-000103:0
20,000 股0Common StockSEC:0000904454-22-000165:0
7,000 股@ US$2.1175100.0% 占其流量Common StockSEC:0001610618-21-000084:0
标准退出：2021年12月12日 (T+90)
5 条申报中的 5 条
About Franson Timothy R
Timothy R. Franson is a Board Member at Cidara Therapeutics, Inc. and Paratek Pharmaceuticals, Inc. He brings his expertise to the board, contributing to strategic decision-making for these companies. His role includes overseeing operations and protecting shareholder interests. Through his experience, he helps guide the future direction of the companies.
